Ashley Gallagher, MA

A secret shopper study finds most are still compounding semaglutide and tirzepatide with additives, often through suppliers lacking sterile compounding licenses.

Bivalent mRNA and protein-based fourth doses produce comparable protection against Omicron JN.1 infection over 12 months.

Pharmacist credentialing unlocks payer contracts and boosts reimbursement and can help avoid risky third-party billing as clinical services expand.

A rapidly growing multistate cyclosporiasis outbreak has pushed national case counts to nearly 7000.

Nine pharmacy organizations state that the revised charter overemphasizes vaccine risk and could delay recommendations pharmacists rely on for scope of practice and insurance coverage.

Lipfendra (enlicitide) showed placebo-adjusted low-density lipoprotein cholesterol reductions of more than 50% in 2 phase 3 trials.

Emerging data show glucagon-like peptide-1 receptor agonists may raise the risk of certain autoimmune diseases compared with other diabetes drugs.

Investigators test 3 repurposed drugs alongside specialist care, finding small, transient fatigue improvements for long COVID fatigue.

New research links a national surge in poison control calls involving semaglutide to preventable dosing mistakes rather than intentional misuse.

Subcutaneous lecanemab-irmb can now be self-administered or given by a caregiver from the first dose, eliminating the requirement for an initial in-clinic intravenous infusion.

A new analysis shows that socioeconomic status shrinks type 2 diabetes risk far more for nonHispanic white and Asian Americans than for nonHispanic Black and Hispanic Americans.

A newly published review traces chikungunya's re-emergence to a record 2025 outbreak in China, and 2 FDA-approved vaccines shape prevention strategy for pharmacists.

Diyaben Patel, PharmD, discusses where artificial intelligence is genuinely transforming pharmacy practice.

New case-control study finds that patients with type 2 diabetes and more severe depressive symptoms show higher cortisol, higher hemoglobin A1C, and lower insulin.

A new surveillance study shows pneumococcal vaccine shifts cut key antibiotic resistance for invasive pneumococcal disease.

West Nile virus cases rise early in 2026, with Arizona leading with 32 cases.

In-home pharmacist visits uncover medication risks, improve adherence and deprescribing, and help older adults stay safer at home.

Pharmacists are being asked to serve as the frontline correctors of medical misinformation, but the emotional labor and repetition are compounding the severe burnout crisis.

CDC-led VISION interim data show 2025-2026 COVID-19 shots cut adult emergency room visits and hospitalizations.

Data show bone density and lean mass losses can be clinically meaningful, but case reports point to resistance training as effective countermeasures.

FDA staff review recommends against adding 7 peptides to the 503A bulk list, citing gaps in characterization, effectiveness, and safety data.

The filing acceptance marks a step toward lower-cost alternatives to Mounjaro and Zepbound.

Updated charter shifts committee governance to the CDC director and drops fixed meeting schedules.

New analyses from the MAESTRO program and real-world studies bolster the evidence base for the metabolic dysfunction-associated steatohepatitis therapy.

A new sibling-matched cohort study challenges earlier observational data, offering pharmacists evidence-based reassurance to share with pregnant patients.

Coadministering COVID-19 and influenza vaccines did not raise the 90-day risk of serious or clinically meaningful adverse events.

As cases approach the full-year 2025 total, declining vaccination coverage and vaccine hesitancy put pharmacists on the front lines of a public health crisis.

The approval extends risankizumab to children 6 years and older and introduces a new weight-based 55 mg prefilled syringe.

Independent pharmacies turn software into profit through smarter purchasing, real-time benefits, medical billing, and OTC prompts that boost margins and care.

Pharmacists turn summit insights into decisive change, boosting independent pharmacy leadership, clinical care, and readiness for 2026 reform.